Cargando…
Yeast display biopanning identifies human antibodies targeting glioblastoma stem-like cells
Glioblastoma stem-like cells (GSC) are hypothesized to evade current therapies and cause tumor recurrence, contributing to poor patient survival. Existing cell surface markers for GSC are developed from embryonic or neural stem cell systems; however, currently available GSC markers are suboptimal in...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696472/ https://www.ncbi.nlm.nih.gov/pubmed/29158489 http://dx.doi.org/10.1038/s41598-017-16066-1 |